Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

被引:41
|
作者
Dilley, James [1 ]
Burnell, Matthew [1 ]
Gentry-Maharaj, Aleksandra [1 ]
Ryan, Andy [1 ]
Neophytou, Christina [1 ]
Apostolidou, Sophia [1 ]
Karpinskyj, Chloe [1 ]
Kalsi, Jatinderpal [11 ]
Mould, Tim [2 ]
Woolas, Robert [3 ]
Singh, Naveena [4 ]
Widschwendter, Martin [11 ]
Fallowfield, Lesley [5 ]
Campbell, Stuart [6 ]
Skates, Steven J. [7 ,8 ]
McGuire, Alistair [9 ]
Parmar, Mahesh [1 ]
Jacobs, Ian [10 ]
Menon, Usha [1 ]
机构
[1] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, 2nd Floor, London WC1V 6LJ, England
[2] Univ Coll London Hosp, London, England
[3] Queen Alexandra Hosp, Portsmouth, Hants, England
[4] Barts Hlth NHS Trust, London, England
[5] Univ Sussex, Brighton & Sussex Med Sch, Sussex Hlth Outcomes Res & Educ Canc SHORE C, Brighton, E Sussex, England
[6] Create Hlth London, London, England
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] London Sch Econ, London, England
[10] Univ New South Wales, Sydney, NSW, Australia
[11] UCL, Inst Womens Hlth, London, England
基金
英国医学研究理事会;
关键词
Ovarian cancer; Symptoms; Routes to diagnosis; Survival; UKCTOCS; GOFF index; NICE; PREDICTIVE-VALUE; WOMEN; OUTCOMES; TIME; DELAY; STAGE;
D O I
10.1016/j.ygyno.2020.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. There are widespread efforts to increase symptom awareness of 'pelvic/abdominal pain, increased abdominal size/bloating, difficulty eating/feeling full and urinary frequency/urgency' in an attempt to diagnose ovarian cancer earlier. Long-term survival of women with these symptoms adjusted for known prognostic factors is yet to be determined. This study explored the association of symptoms, routes and interval to diagnosis and long-term survival in a population-based cohort of postmenopausal women diagnosed with invasive epithelial tubo-ovarian cancer (iE0C) in the 'no screen' (control) UKCTOCS arm. Methods. Of 101,299 women in the control arm. 574 were confirmed on outcome review to have iE0C between randomisation (2001-2005) and 31 December 2014. Data was extracted from medical notes and electronic records. A multivariable model was fitted for individual symptoms, time interval from symptom onset to diagnosis, route to diagnosis, speciality, morphological Type, age at diagnosis, year of diagnosis (period effect), stage, primary treatment, and residual disease. Results. Women presenting with symptoms listed in the NICE guidelines (HR1.48, 95%CI 1.16-1.89, p = 0.001) or the modified Goff Index (HR1- 68, 95%CI 1.32-2.13, p < 0.0001) had significantly worse survival than those who did not. Each additional presenting symptom decreased survival (HR1.20, 95%CI 1.12-1.28, p < 0.0001). In multivariable analysis, in addition to advanced stage, increasing residual disease and inadequate primary treatment, abdominal pain and loss of appetite/feeling full were significantly associated with increased mortality. Conclusions. The ovarian cancer symptom indices identify postmenopausal women with a poorer prognosis. This study however cannot exclude the possibility of better outcomes in those who are aware and act on their symptoms. (C) 2020 The Authors. Published by Elsevier Inc.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [41] Impact of Rurality on Stage IV Ovarian Cancer at Diagnosis: A Midwest Cancer Registry Cohort Study
    Weeks, Kristin S.
    Lynch, Charles F.
    West, Michele
    McDonald, Megan
    Carnahan, Ryan
    Stewart, Sherri L.
    Charlton, Mary
    JOURNAL OF RURAL HEALTH, 2020, 36 (04) : 468 - 475
  • [42] Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening
    Gentry-Maharaj, A.
    Karpinskyj, C.
    Glazer, C.
    Burnell, M.
    Bailey, K.
    Apostolidou, S.
    Ryan, A.
    Lanceley, A.
    Fraser, L.
    Jacobs, I.
    Hunter, M. S.
    Menon, U.
    CLIMACTERIC, 2017, 20 (03) : 240 - 247
  • [43] Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study
    Park, Jeong-Yeol
    Lim, Myong Cheol
    Baek, Min-Hyun
    Park, Young-Han
    Kim, Seonok
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (04)
  • [44] Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study
    Baun, Marie-Louise L.
    Jensen, Henry
    Falborg, Alina Z.
    Heje, Hanne N.
    Petersen, Lone K.
    Vedsted, Peter
    FAMILY PRACTICE, 2019, 36 (06) : 751 - 757
  • [45] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [46] Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening
    Jenkins, Valerie
    Fallowfield, Lesley
    Langridge, Carolyn
    Barrett, Jessica
    Ryan, Andy
    Jacobs, Ian
    Kilkerr, Justine
    Menon, Usha
    Farewell, Vernon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) : 1519 - 1525
  • [47] Complications after advanced ovarian cancer surgery-A population-based cohort study
    Palmqvist, Charlotte
    Michaelsson, Hanna
    Staf, Christian
    Johansson, Mia
    Albertsson, Per
    Dahm-Kahler, Pernilla
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2022, 101 (07) : 747 - 757
  • [48] Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life
    Price, M. A.
    Bell, M. L.
    Sommeijer, D. W.
    Friedlander, M.
    Stockler, M. R.
    deFazio, A.
    Webb, P. M.
    Butow, P. N.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 162 - 168
  • [49] A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK
    White, Alan
    Ironmonger, Lucy
    Steele, Robert J. C.
    Ormiston-Smith, Nick
    Crawford, Carina
    Seims, Amanda
    BMC CANCER, 2018, 18
  • [50] Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study
    Sigrun A Johannesdottir
    Morten Schmidt
    Gary Phillips
    Ronald Glaser
    Eric V Yang
    Michael Blumenfeld
    Stanley Lemeshow
    BMC Cancer, 13